4D Molecular Therapeutics(FDMT)
$12.99+0.53 (+4.25%)
FDMT
4D Molecular Therapeutics financials statements
$12.99
At close:+0.53 (+4.25%)
Want to see FDMT full AI Analyst Report?
4D Molecular Therapeutics (FDMT) Financial Statements
534 Followers
4D Molecular Therapeutics Financial Overview
4D Molecular Therapeutics's market cap is currently $688.34M. The company's EPS TTM is $-2.72; its P/E ratio is -4.78; 4D Molecular Therapeutics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 85.21M | $ 37.00K | $ 20.72M | $ 3.13M | $ 18.04M |
| Gross Profit | $ 77.58M | $ -141.26M | $ -76.37M | $ -77.12M | $ -43.32M |
| Operating Income | $ -159.55M | $ -187.84M | $ -112.87M | $ -110.03M | $ -71.33M |
| EBITDA | $ -132.48M | $ -154.16M | $ -95.09M | $ -103.61M | $ -68.30M |
| Net Income | $ -140.11M | $ -160.87M | $ -100.84M | $ -107.49M | $ -71.32M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 402.65M | $ 424.88M | $ 288.23M | $ 213.55M | $ 247.78M |
| Total Assets | $ 566.71M | $ 560.38M | $ 339.89M | $ 261.85M | $ 353.49M |
| Total Debt | $ 21.41M | $ 24.61M | $ 14.67M | $ 16.12M | $ 16.45M |
| Net Debt | $ -38.83M | $ -124.73M | $ -234.44M | $ -36.23M | $ -136.55M |
| Total Liabilities | $ 61.05M | $ 49.78M | $ 32.06M | $ 30.51M | $ 34.38M |
| Stockholders' Equity | $ 505.66M | $ 510.61M | $ 307.83M | $ 231.34M | $ 319.11M |
| Cash Flow | |||||
| Free Cash Flow | $ -109.62M | $ -138.37M | $ -78.56M | $ -98.22M | $ -78.24M |
| Operating Cash Flow | $ -109.08M | $ -134.59M | $ -75.79M | $ -86.69M | $ -69.13M |
| Investing Cash Flow | $ -92.97M | $ -302.44M | $ 115.72M | $ -17.05M | $ -172.68M |
| Financing Cash Flow | $ 112.96M | $ 337.25M | $ 156.83M | $ 3.08M | $ 118.09M |
Currency in USD
